Form 4 for KYNB KYNTRA BIO, INC.
Accepted 2022-07-08 00:00:00 ET · period of report 2022-07-06 · accession 0001209191-22-041664 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-07-08 | 2022-07-06 | KYNB | Conterno Enrique A | CEO, Dir | F - Tax | $12.40 | -1,296 | 302.6K | -0.4% | -$16.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-06 | F | D | 1,296 | $12.40 | 302,631 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy a tax obligation realized by the reporting person upon the vesting of restricted stock units. (F2) Includes 1,987 shares acquired on May 13, 2022 through the Issuer's Employee Stock Purchase Plan. |